This study published in Lancet Psychiatry examines medication adherence as a mediator of the association between continued cannabis use following illness onset and relapse, as indexed by admission to hospital, in patients with first-episode psychosis.
Wednesday, 9 August 2017
Cannabis use in patients with first-episode psychosis
Cannabis use following the onset of first-episode psychosis has been linked to both increased risk of relapse and non-adherence with antipsychotic medication. Whether poor outcome associated with cannabis use is mediated through an adverse effect of cannabis on medication adherence is unclear.
This study published in Lancet Psychiatry examines medication adherence as a mediator of the association between continued cannabis use following illness onset and relapse, as indexed by admission to hospital, in patients with first-episode psychosis.
This study published in Lancet Psychiatry examines medication adherence as a mediator of the association between continued cannabis use following illness onset and relapse, as indexed by admission to hospital, in patients with first-episode psychosis.
The Lancet Psychiatry , 4 (8), 627 - 633 Open access
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment